Polymorphisms in arsenic (+ 3 oxidation state) methyltransferase (AS3MT) predict the occurrence of hyperleukocytosis and arsenic metabolism in APL patients treated with As2O3
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Polymorphisms in arsenic (+ 3 oxidation state) methyltransferase (AS3MT) predict the occurrence of hyperleukocytosis and arsenic metabolism in APL patients treated with As2O3
Authors
Keywords
-
Journal
ARCHIVES OF TOXICOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-02-29
DOI
10.1007/s00204-020-02686-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Influence of AS3MT polymorphisms on arsenic metabolism and liver injury in APL patients treated with arsenic trioxide
- (2019) Jing Lu et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Differentiation syndrome in acute promyelocytic leukaemia
- (2019) Maximilian Stahl et al. BRITISH JOURNAL OF HAEMATOLOGY
- Progressive hyperleukocytosis is a relevant predictive marker for differentiation syndrome, early death, and subsequent relapse in acute promyelocytic leukemia
- (2019) Jae-Ho Yoon et al. Scientific Reports
- Clinical pharmacokinetics and safety profile of single agent arsenic trioxide by continuous slow-rate infusion in patients with newly diagnosed acute promyelocytic leukemia
- (2018) Chunlu Gao et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Serum homocysteine, arsenic methylation, and arsenic-induced skin lesion incidence in Bangladesh: A one-carbon metabolism candidate gene study
- (2018) Megan M. Niedzwiecki et al. ENVIRONMENT INTERNATIONAL
- Arsenic trioxide is required in the treatment of newly diagnosed acute promyelocytic leukemia. Analysis of a randomized trial (APL 2006) by the French Belgian Swiss APL group
- (2018) Lionel Adès et al. HAEMATOLOGICA
- Role of arsenic (+3 oxidation state) methyltransferase in arsenic mediated APL treatment: an in vitro investigation
- (2018) Yasen Maimaitiyiming et al. Metallomics
- Arsenic trioxide is required in the treatment of newly diagnosed acute promyelocytic leukemia. Analysis of a randomized trial (APL 2006) by the French Belgian Swiss APL group
- (2018) Lionel Adès et al. HAEMATOLOGICA
- Corrigendum to “Polymorphisms of Arsenic (+3 Oxidation State) Methyltransferase and Arsenic Methylation Capacity Affect the Risk of Bladder Cancer”
- (2018) Ying-Chin Lin et al. TOXICOLOGICAL SCIENCES
- AS3MT Polymorphisms, Arsenic Metabolism, and the Hematological and Biochemical Values in APL Patients Treated with Arsenic Trioxide
- (2018) Jing Lu et al. TOXICOLOGICAL SCIENCES
- Relative miRNA and mRNA expression involved in arsenic methylation
- (2018) Huirong Cheng et al. PLoS One
- Arsenic metabolites; selenium; and AS3MT, MTHFR, AQP4, AQP9, SELENOP, INMT, and MT2A polymorphisms in Croatian-Slovenian population from PHIME-CROME study
- (2018) Anja Stajnko et al. ENVIRONMENTAL RESEARCH
- The Association of Arsenic Metabolism with Cancer, Cardiovascular Disease, and Diabetes: A Systematic Review of the Epidemiological Evidence
- (2017) Chin-Chi Kuo et al. ENVIRONMENTAL HEALTH PERSPECTIVES
- HPLC-HG-AFS determination of arsenic species in acute promyelocytic leukemia ( APL) plasma and blood cells
- (2017) Meihua Guo et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Metabolism, toxicity and anticancer activities of arsenic compounds
- (2017) Islam Khairul et al. Oncotarget
- Prognostic factors in acute promyelocytic leukemia: strategies to define high-risk patients
- (2016) Ugo Testa et al. ANNALS OF HEMATOLOGY
- Biological and behavioral factors modify urinary arsenic metabolic profiles in a U.S. population
- (2016) Edward E. Hudgens et al. Environmental Health
- Interactive Influence ofN6AMT1andAs3MTGenetic Variations on Arsenic Metabolism in the Population of Inner Mongolia, China
- (2016) Xushen Chen et al. TOXICOLOGICAL SCIENCES
- Factors Affecting Arsenic Methylation in Arsenic-Exposed Humans: A Systematic Review and Meta-Analysis
- (2016) Hui Shen et al. International Journal of Environmental Research and Public Health
- Induction, consolidation, and maintenance therapies with arsenic as a single agent for acute promyelocytic leukaemia in a 11-year follow-up
- (2015) Mozaffar Aznab et al. HEMATOLOGICAL ONCOLOGY
- Methylated arsenic metabolites bind to PML protein but do not induce cellular differentiation and PML-RARα protein degradation
- (2015) Qian Qian Wang et al. Oncotarget
- Clinical characteristics and outcomes in patients with acute promyelocytic leukaemia and hyperleucocytosis
- (2014) Naval Daver et al. BRITISH JOURNAL OF HAEMATOLOGY
- Chemical Mechanism of Arsenic Biomethylation
- (2014) William R. Cullen CHEMICAL RESEARCH IN TOXICOLOGY
- Prevalence, Management, and Clinical Consequences of QT Interval Prolongation During Treatment With Arsenic Trioxide
- (2014) Gail J. Roboz et al. JOURNAL OF CLINICAL ONCOLOGY
- Metabolism of arsenic and its toxicological relevance
- (2012) Takayuki Watanabe et al. ARCHIVES OF TOXICOLOGY
- Long-term efficacy and safety of arsenic trioxide for first-line treatment of elderly patients with newly diagnosed acute promyelocytic leukemia
- (2012) Yingmei Zhang et al. CANCER
- Arsenic methylation, GSTO1 polymorphisms, and metabolic syndrome in an arseniasis endemic area of southwestern Taiwan
- (2012) Jein-Wen Chen et al. CHEMOSPHERE
- Arsenic methylation metabolism and liver injury of acute promyelocytic leukemia patients undergoing arsenic trioxide treatment
- (2011) Huihui Wang et al. ENVIRONMENTAL TOXICOLOGY
- Individual Variations in Inorganic Arsenic Metabolism Associated with AS3MT Genetic Polymorphisms
- (2011) Tetsuro Agusa et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Association of AS3MT polymorphisms and the risk of premalignant arsenic skin lesions
- (2009) Olga L. Valenzuela et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Acute promyelocytic leukemia: from highly fatal to highly curable
- (2008) Z.-Y. Wang et al. BLOOD
- Asian specific low mutation frequencies of the M287T polymorphism in the human arsenic (+3 oxidation state) methyltransferase (AS3MT) gene
- (2008) Junko Fujihara et al. MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now